| Target and Pathway |
Top |
| Target(s) |
Intercellular adhesion molecule ICAM-1 (ICAM1) |
Target Info
|
. |
[2] |
| Tyrosine-protein kinase UFO (AXL) |
Target Info
|
Inhibitor |
[1] |
|
KEGG Pathway
|
NF-kappa B signaling pathway
|
|
Cell adhesion molecules (CAMs)
|
|
Natural killer cell mediated cytotoxicity
|
|
TNF signaling pathway
|
|
Leukocyte transendothelial migration
|
|
African trypanosomiasis
|
|
Malaria
|
|
Staphylococcus aureus infection
|
|
Influenza A
|
|
HTLV-I infection
|
|
Epstein-Barr virus infection
|
|
Rheumatoid arthritis
|
|
Viral myocarditis
|
|
NetPath Pathway
|
IL5 Signaling Pathway
|
|
IL1 Signaling Pathway
|
|
TSH Signaling Pathway
|
|
IL6 Signaling Pathway
|
|
IL2 Signaling Pathway
|
|
ID Signaling Pathway
|
|
TWEAK Signaling Pathway
|
|
RANKL Signaling Pathway
|
|
TNFalpha Signaling Pathway
|
|
FSH Signaling Pathway
|
|
Pathway Interaction Database
|
Thromboxane A2 receptor signaling
|
|
Glucocorticoid receptor regulatory network
|
|
amb2 Integrin signaling
|
|
Beta2 integrin cell surface interactions
|
|
Validated transcriptional targets of deltaNp63 isoforms
|
|
Reactome
|
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
|
|
Integrin cell surface interactions
|
|
Interferon gamma signaling
|
|
VEGFA-VEGFR2 Pathway
|
|
WikiPathways
|
Type II interferon signaling (IFNG)
|
|
IL1 and megakaryotyces in obesity
|
|
Human Complement System
|
|
Spinal Cord Injury
|
|
Interleukin-11 Signaling Pathway
|
|
RANKL/RANK Signaling Pathway
|
|
Integrin cell surface interactions
|
|
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
|
|
Folate Metabolism
|
|
Vitamin B12 Metabolism
|
|
Selenium Micronutrient Network
|
|
miR-targeted genes in squamous cell - TarBase
|
|
miR-targeted genes in muscle cell - TarBase
|
|
miR-targeted genes in lymphocytes - TarBase
|
